UnitedHealth Group Revenues Stung by Obamacare

By Trey Thoelcke Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

UnitedHealth Group Inc. (NYSE: UNH) reported first-quarter results before markets opened Thursday. The health insurance and benefits management firm posted diluted earnings per share (EPS) of $1.10 on revenues of $31.7 billion. In the same period a year ago, UnitedHealth reported EPS of $1.16 on $30.34 billion in revenue. First-quarter results also compare to the consensus estimates for EPS of $1.09 on revenues of $31.99 billion.

ALSO READ: Jefferies’ Cheapest Health Care Stocks to Buy

The company’s CEO said:

We performed steadily in the first quarter, with continued momentum from our Optum health services platform and year-over-year growth across our UnitedHealthcare health benefits platform offset by headwinds from new ACA taxes and Medicare Advantage funding deficiencies. We continue to help enable a more effective, more modern health care system that better serves consumers and responds to a national imperative to improve the performance of health care and reduce its costs.

The company said it repurchased $911 million in stock in the first quarter, acquiring more than 12 million shares at an average price of approximately $75 per share. Also it distributed $276 million in dividends to shareholders, representing dividend growth of 28% year-over-year.

For the full year, the company reaffirmed its forecast for revenues of $128 billion to $129 billion, with EPS in a range of $5.40 to $5.60. The consensus forecast for the full year so far calls for $5.59 per share on $128.92 billion. For the current quarter, the estimates are $1.33 per share earnings and $32.04 billion in revenue.

Note that Citigroup downgraded the stock to Neutral from Buy ahead of the earnings report.

Shares were inactive in premarket trading Thursday, after ending Wednesday at $78.19, in a 52-week range of $58.03 to $83.32. Thomson Reuters had a consensus analyst price target of around $85.09 before the results were announced.

ALSO READ: Jefferies Stocks to Buy That Could Jump From an Earnings Surprise

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

ALB Vol: 4,532,355
+$9.50
+5.83%
$172.54
EXE Vol: 5,642,149
+$4.87
+4.88%
$104.75
STZ Vol: 3,922,780
+$7.00
+4.47%
$163.64
NEM Vol: 11,144,857
+$4.82
+4.22%
$118.94
MNST Vol: 7,338,925
+$3.30
+4.22%
$81.47

Top Losing Stocks

NTAP Vol: 5,231,295
-$9.73
9.37%
$94.11
DELL Vol: 11,616,219
-$9.46
7.85%
$111.07
NCLH Vol: 30,184,521
-$1.64
7.45%
$20.37
3M
MMM Vol: 11,901,735
-$11.68
6.96%
$156.12
LULU Vol: 4,308,474
-$13.11
6.49%
$188.76